about
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the fieldDistinct eosinophil cytokine expression patterns in skin diseases - the possible existence of functionally different eosinophil subpopulations.Diagnosis of primary pulmonary T- cell/histiocyte-rich large B cell lymphoma with tissue eosinophilia via clinicopathological observation and molecular assay.Is chronic asthma associated with shorter leukocyte telomere length at midlife?Novel targeted therapies for eosinophil-associated diseases and allergyInhibition of NF-κB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice.Role of mucosal inflammation in eosinophilic esophagitis: review of the literatureEP4 receptor stimulation down-regulates human eosinophil function.Toxicity of eosinophil MBP is repressed by intracellular crystallization and promoted by extracellular aggregation.Leukocyte-associated Ig-like receptor-1-deficient mice have an altered immune cell phenotype.Refining the definition of hypereosinophilic syndrome.Evaluation and differential diagnosis of marked, persistent eosinophilia.Novel targeted therapies for eosinophilic disordersICON: Eosinophil DisordersOrigin, regulation and physiological function of intestinal oeosinophils.Glycoproteomic analysis of plasma from patients with atopic dermatitis: CD5L and ApoE as potential biomarkers.Multisystemic eosinophilia resembling hypereosinophilic syndrome in a colony-bred owl monkey (Aotus vociferans)Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen-induced pulmonary inflammation in mice.Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract.An approach to the hospitalized patient with urticaria and fever.Eosinophilic digestive disease (EDD) and allergic bronchial asthma; two diseases or expression of one disease in two systems?Eosinophilic disorders in various diseases.Clinical overview of cutaneous features in hypereosinophilic syndrome.Clinical management of the hypereosinophilic syndromes.Oncostatin M is a FIP1L1/PDGFRA-dependent mediator of cytokine production in chronic eosinophilic leukemia.Kaempferol suppresses eosionphil infiltration and airway inflammation in airway epithelial cells and in mice with allergic asthma.Human eosinophils release IL-1ß and increase expression of IL-17A in activated CD4+ T lymphocytesRegulatory Eosinophils Suppress T Cells Partly through Galectin-10.Neglected infections of poverty in Texas and the rest of the United States: management and treatment options.An epigenome-wide association study of total serum IgE in Hispanic children.A patient with shortness of breath and bilateral pulmonary infiltrates.Eosinophilia in a cat with acute leukemia.Acute Eosinophilic Myocarditis and Hyper IgE in HIV Infection: A Case Report.Glucocorticosteroid-sensitive inflammatory eosinophilic pseudotumor of the bladder in an adolescent: a case report.Eosinophilia in routine blood samples and the subsequent risk of hematological malignancies and death.Eosinophilia and allergic disorders in autoimmune pancreatitis.Evidence for a role of eosinophils in blister formation in bullous pemphigoid.RhoH is a negative regulator of eosinophilopoiesis.Eosinophils as putative therapeutic targets in bullous pemphigoid.Eosinophilia secondary to lenalidomide therapy.
P2860
Q27003331-57CDADDE-0D23-4878-B350-283ED78DDCBDQ34007831-8C1CA696-FE33-4E9D-B5BC-B5C436F6DF29Q34392965-57F5046B-8BA4-4B1C-83F9-109E0356236BQ34425969-864E048F-D005-4005-B42B-58B40A1CBF96Q34444620-D4AC90D2-7E91-45DE-9075-341CEB8E1662Q34768640-8E5C5B8B-B485-4A45-AA83-957AFD4EB042Q35200699-A5932022-B5BD-4FDC-9194-259A39D57EFCQ35332774-CB7C91D6-7D67-4AD1-9CE4-9689D8B1132CQ35569801-0E7E245F-93D9-45C8-BC82-C85500286CB1Q35776073-D33C28B3-B8C6-4F40-BBD9-C53C55E5E95FQ36103687-6E5CB8E8-C264-42B6-8010-F9388A482685Q36176737-4DF8A430-870F-4FFF-811E-4C33FE6151F6Q36763565-32867916-B272-4D64-97F1-E26CC360EFA2Q36834826-9265A9B2-3BBC-4D55-BA45-AC14DFDB7B1DQ37168735-71ED2828-9719-486A-B0F5-8BB3D107B5E4Q37185022-7CEE8FC0-1BFA-44C5-9F19-1DE6BC76FAE4Q37228677-DF6C42D4-3927-4BA7-843F-F5CE1A9EA5F5Q37579439-67E3E872-2A54-4229-9EAE-4F722B7E1D5CQ37731037-820CFF00-FE47-4EAD-BB46-6DAF9439DB36Q37853597-C1ED200F-E3AB-4896-9631-7C8550F68E0DQ37865596-01CF307E-7E9C-49C2-BCB6-E5333B32DED1Q37967448-4521201F-AE92-475D-BF39-34C7E328A5BAQ37987470-A5FCCD9E-3DB9-46EB-9397-C383D7121055Q38025157-C0658338-14FE-4DC6-A730-C3926B3C3A8AQ39159911-F5A073D1-AF72-4F6F-B8A3-A3E9760D82B3Q39430436-B242129F-EDB7-4149-9074-960EBEA48529Q39464920-5A9397BF-B2BB-4017-B043-52F17C58E819Q40208709-A3065C69-A19B-4644-AA99-4E31B4B1C1ECQ40281592-48E3C636-E12B-4518-AA68-7EC31246F694Q40388598-220DF82B-FBFE-4370-ACF3-E78FCD0697EAQ41851997-AC965265-349E-4DA5-A7EF-5490F92DFDD0Q41866547-91380816-0DC3-4DA7-83D5-C7BBFB2C01D6Q41971578-D739078F-9CC5-4E48-8904-C6BFBC3401AFQ42940864-09B7398D-FC8F-4B3D-B35D-DF2FFC32B26AQ44007100-8FDE80BF-7874-4ADE-B2F1-80245945BA29Q45882499-C6ED8099-EB4F-4635-9F75-761D602C8172Q46425853-AA4E178A-3917-467C-AF74-6E542B297E6CQ47123399-A7002A1B-9E16-453F-9FE7-C5CF62D0ADEBQ47916162-A4A7AE35-B106-444A-8AAD-0131431ACE64Q48193051-E2178562-7478-4963-90B0-65076430A2B6
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Eosinophilic disorders.
@ast
Eosinophilic disorders.
@en
Eosinophilic disorders.
@nl
type
label
Eosinophilic disorders.
@ast
Eosinophilic disorders.
@en
Eosinophilic disorders.
@nl
prefLabel
Eosinophilic disorders.
@ast
Eosinophilic disorders.
@en
Eosinophilic disorders.
@nl
P1476
Eosinophilic disorders.
@en
P2093
Dagmar Simon
P304
1291-300; quiz 1301-2
P356
10.1016/J.JACI.2007.02.010
P407
P577
2007-04-02T00:00:00Z